Here are relevant reports on : age-verification-market
-
Automated Border Control Market by Solution Type (E-gates, Kiosks), Component Type [Hardware (Document Verification, Biometrics (Facial, Iris Recognition), Software, Services], Application (Airports, Seaports, Land Ports) - Global Forecast to 2030
The automated border control market is expected to grow from USD 2.56 billion in 2025 to USD 5.03 billion by 2030, at a compound annual growth rate (CAGR) of 14.4% during the forecast period. The Key Players (France), Secunet Security Networks AG (Germany), IDEMIA (France), and SITA (Switzerland)Vision-Box (Portugal), NEC Corporation (Japan), Indra Sistemas, S.A. (Spain), Gunnebo AB (Sweden), and HID Global Corporation (US).
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
Middle East & Africa Identity Verification Market by Service, Application (Access Control & User Monitoring, KYC, KYB & Onboarding, Identity Fraud Compliance & Forensics), & Type (Biometrics, Non-Biometrics) - Forecast to 2030
The Middle East & Africa identity verification market is projected to grow from 1.17 billion in 2025 to USD 2.38 billion by 2030, at a CAGR of 15.2% during the forecast period. IDEMIA (France), Thales (France), Entrust (US), Experian (Ireland), LexisNexis Risk Solutions (US), Jumio (US), GBG (UK), AU10TIX (Israel), Shufti Pro (UK), Trulioo (Canada), uqudo (UK), AuthBridge (India), EDC (UAE), IdentifyME (UAE), ID360 (UAE), Mobile Technologies (UAE), BVS Global (UAE), QuadraBay (UAE), Digified (Egypt), and IDMERIT (US) are the key players in the Middle East & Africa identity verification market.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Medication Management Market by Systems (CPOE, CDSS, Automated Dispensing, Assurance Systems), Services (Medication Analytics, POC Verification, ADE Surveillance), Mode of Delivery (On-Premises, Web-Based, Cloud-Based) - Global Forecast to 2019
The global medication management market is expected to grow at a CAGR of 14% till 2019, from $845.1 million in 2014. This can be attributed to the rise in the ageing population, the need for better medication administration, and strong government support initiatives. However, the high cost of software installations and associated maintenance may hinder the growth of this market to a certain extent.
- Published: August 2014
- Price: $ 4950
- TOC Available:
-
US Telehealth & Telemedicine Market by Function (Clinical Care, Teleconsult, RPM, Patient Engagement, Analytics), Application (TeleICU, Teleradiology, Telecardiology, Diabetes), Age (Adult, Pediatric), End User (Hospital, Payer, ASC) - Forecast to 2030
The US Telehealth & Telemedicine Market, valued at US$46.10 billion in 2024, stood at US$51.40 billion in 2025 and is projected to advance at a resilient CAGR of 10.2% from 2025 to 2030, culminating in a forecasted valuation of US$83.63 billion by the end of the period. In the US, permanent CMS reimbursement expansions and state-level payment parity laws are driving telehealth growth by securing fair, ongoing reimbursement comparable to in-person care.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
US Enteral Feeding Devices Market by Type (Nasogastric Tubes, Administration Sets, Nasal Feeding, Nasoduodenal, Syringes, Connectors), Insertion Method, Age Group (Adult, Pediatric), Application (Oncology, Hypermetabolism), End User - Forecast to 2032
The US enteral feeding device market, valued at US$1.13 billion in 2025, stood at US$1.19 billion in 2026 and is projected to advance at a resilient CAGR of 6.1% from 2026 to 2032, culminating in a forecasted valuation of US$1.70 billion by the end of the period.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Asia Pacific Telehealth & Telemedicine Market by Function (Clinical Care, Teleconsult, RPM, Patient Engagement, Analytics), Application (TeleICU, Teleradiology, Telecardiology), Age (Adults, Pediatrics), End User (Hospitals, ASCs, Payers) - Forecast to 2030
The Asia Pacific telehealth & telemedicine market, valued at US$18.22 billion in 2024, stood at US$21.04 billion in 2025 and is projected to advance at a resilient CAGR of 14.2% from 2024 to 2030, culminating in a forecasted valuation of US$40.83 billion by the end of the period. The growth of the telehealth and telemedicine market in the region is driven by rising demand for remote healthcare delivery, digital health platforms, and virtual care solutions that improve accessibility, efficiency, and cost-effectiveness across diverse population groups.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Blood Pressure Cuffs Market By Type (Automated, Manual), Size, Usage (Reusable, Disposable), Age Group (Adults, Infants & Children), Distribution Channel (Retail, Online), End User (Hospitals, Clinics, Homecare), Region-Global Forecast to 2032
The global blood pressure cuffs market, valued at US$0.6 billion in 2024, stood at US$0.7 billion in 2025 and is projected to advance at a resilient CAGR of 9.0% from 2025 to 2032, culminating in a forecasted valuation of US$1.3 billion by the end of the period. This growth is primarily fueled by the expanding elderly population, which is at a higher risk of developing hypertension and associated cardiovascular complications.
- Published: June 2025
- Price: $ 4950
- TOC Available:
-
Sleep Apnea Oral Appliances Market by Product (Mandibular Advancement Devices (MAD), Tongue-Retaining Devices (TRD)), Purchase Type (Physician-prescribed), Gender (Male, Female), Age Group, Distribution Channel (Online, Retail) - Global Forecast to 2030
The global sleep apnea oral appliances market, valued at US$0.4B in 2024, is forecasted to grow at a 9.8% CAGR, reaching US$0.5B by 2025 and US$0.8B by 2030.
- Published: May 2025
- Price: $ 4950
- TOC Available:
-
Vitamin D Therapy Market by Route of administration (Oral, Parenteral), Age Group (Children, Adult, Senior Adult), Purchase Pattern (OTC, Prescription), Application (Osteoporosis, Rickets, Autoimmune Disorder, Skin Diseases) - Global Forecast to 2024
The vitamin D therapy market is projected to reach USD 3.3 billion by 2024 from USD 1.9 billion in 2019, at a CAGR of 11.6% during the forecast period. Growth in this market is largely driven by the growing awareness about vitamin D deficiency and the presence of a large target patient population. On the other hand, the fortification of foods is likely to challenge the growth of this market. Some of the major players in this market include Abbott (US), Sanofi (France), GlaxoSmithKline plc (UK), Pfizer Inc. (US), Merck & Co., Inc. (US), Torrent Pharmaceuticals Ltd. (India), Novartis International AG (Switzerland), Alkem Laboratories (India), Sun Pharmaceutical Industries Ltd. (India), and Cadila Healthcare Ltd. (India).
- Published: April 2019
- Price: $ 4950
- TOC Available:
-
Pulse Oximeter Market by Product (Equipment, Sensor), Type [Portable (Handheld, Wearable, Fingertip), Bedside], Technology (Conventional, Connected), Age Group (Adult, Infant, Neonatal), End User (Hospitals, Home Care), Region - Global Forecast to 2032
The global pulse oximeter market, valued at US$3.59 billion in 2024, stood at US$3.92 billion in 2025 and is projected to advance at a resilient CAGR of 8.7% from 2025 to 2032, culminating in a forecasted valuation of US$7.03 billion by the end of the period. The growth of this market is primarily driven by the rising prevalence of respiratory diseases, increasing prevalence of congenital heart disease (CHD) in children, a growing number of surgical procedures and hospitalizations, an increasing geriatric population, and subsequent rise in chronic diseases, technological advancements in pulse oximeter devices, growing investments in healthcare infrastructure, and the outbreak of infectious respiratory diseases.
- Published: June 2025
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
